Robert Beardsley

Robert Alan Beardsley was the founder of Galera Therapeutics, Inc., founded in 2009, where the title held was Chief Operating Officer from 2017 to 2024.
Dr. Beardsley is also the founder of Simile Investors LLC..
Dr. Beardsley is President & Chief Executive Officer at Cirius Therapeutics, Inc. since 2024.
Dr. Beardsley is Director at Nomax Therapeutics, Inc. Dr. Beardsley is Independent Director at Arbutus Biopharma Corp.
starting 2025.
Former positions include President & Chief Executive Officer at Kereos, Inc. from 2003 to 2012; Chief Executive Officer at Metabolic Solutions Development Co. LLC.
from 2009 to 2010; Chairman & Chief Executive Officer at Galera Labs LLC in 2012; Chief Executive Officer at Metaphore Pharmaceuticals, Inc. from 2000 to 2006; Chairman at Epigenetx LLC; Director at CollaGenex Pharmaceuticals, Inc. from 2004 to 2008; Director at Zevra Therapeutics, Inc.; Director at Euclises Pharmaceuticals, Inc.; Director at BioSeek, Inc.; Director at PharmaMonde, Inc.; Chief Business Officer at Aclaris Life Sciences, Inc.; Principal at Vector Securities International, Inc. from 1994 to 1995; Principal at Biostrategies Group from 1997 to 2002.
Education includes an MBA from The University of Chicago and a doctorate from the University of Iowa.